CN Patent

CN104797574B — Lfa-1抑制剂及其多晶型物

Assigned to Bausch and Lomb Ireland Ltd · Expires 2019-11-22 · 6y expired

What this patent protects

本发明公开了化合物的制备和纯化方法、其中间体、其多晶型物以及相关的化合物。本申请还公开了所述化合物的制剂及其在治疗LFA‑1介导的疾病中的用途。

USPTO Abstract

本发明公开了化合物的制备和纯化方法、其中间体、其多晶型物以及相关的化合物。本申请还公开了所述化合物的制剂及其在治疗LFA‑1介导的疾病中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN104797574B
Jurisdiction
CN
Classification
—
Expires
2019-11-22
Drug substance claim
No
Drug product claim
No
Assignee
Bausch and Lomb Ireland Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.